Endomag

Endomag is a medical technology company dedicated to improving the standard of cancer care worldwide. Endomag's Sentimag® probe, Magseed® marker, and Magtrace® lymphatic mapping agent have been utilized by many of the world's leading physicians and cancer centers. The goal is to help women with breast cancer avoid surgery when it is unnecessary and achieve better outcomes when surgery is required. We have already helped tens of thousands of women globally receive more precise and less invasive breast cancer care. Founded in 2007 as a spin-off from the University of Houston and University College London (UCL), the company will continue to develop its unique clinical platform through its headquarters located in Cambridge, UK.